Table 2 Baseline characteristics of analyzed PMBCL patients.
From: Enhancing prognostic accuracy in PMBCL: semiquantitative analysis of interim PET/CT scans
Features | iPET negative (n = 28) | iPET positive(n = 62) | P- value |
|---|---|---|---|
Median age, years (range) | 38 (19–61) | 36 (20–67) | 0.579 |
Sex | 0.747 | ||
male | 10 | 20 | |
female | 18 | 42 | |
B symptom | 0.069 | ||
Yes | 10 | 35 | |
No | 18 | 27 | |
LDH | 0.536 | ||
Elevated | 23 | 54 | |
Normal | 5 | 8 | |
ECOG | 0.948 | ||
0 | 10 | 19 | |
1 | 13 | 31 | |
2 | 3 | 6 | |
3 | 2 | 6 | |
Extranodal involvement | 0.887 | ||
Yes | 14 | 32 | |
No | 14 | 30 | |
Bone marrow involvement | 0.503 | ||
Yes | 0 | 1 | |
No | 27 | 60 | |
IPI | 0.629 | ||
N/A | 0 | 1 | |
Low | 15 | 33 | |
Low intermediate | 7 | 18 | |
High intermediate | 3 | 8 | |
High | 3 | 2 | |
Metric PET analyzed subgroup | iPET negative (n = 11) | iPET positive (n = 24) | |
MTV (mean, cm3) | 242 | 198 | 0.901 |
SUVmax (mean) | 20 | 22 | 0.547 |
TLG (mean) | 2634 | 2797 | 0.695 |
